Seller reserves to itself all applicable duty drawback allowances, and Buyer shall provide assistance in connection with Seller’s application for the same. 11. Satıcı, Satıcı tarafından tedarik edilmiş olsun veya olmasın, Alıcı tarafından kullanılan boşaltma veya indirme ekipman veya materyallerin çalışmamasından sorumlu değildir. 11.

Seller reserves to itself all applicable duty drawback allowances, and Buyer shall provide assistance in connection with Seller’s ap- plication for the same. 11. Säljaren förbehåller sig rätten till tullrestitution, och Köparen ska tillhandahålla hjälp i samband med Säljarens ansökan om sådan. 11.

یعوضالضرائب والمصروفات والرسوم. 10 أو اإلقلیمیة أو المحلیة أو غیرھا (بخالف بالوالیة الضرائب االتحادیة أو الخاصة ضرائب اإلنتاج أو المصروفات التي تشمل الضرائب ضرائب الدخل) أو والمصروفات التعویضیة الحكومیة، والتي یجب على البائع سدادھا فیما یتعلق ھذه المبالغ فقط غیر متضمنة في السعر عند بدایة كونوت بتصنیع وتورید المنتج، ھذا العقد، ویحتفظ البائع لنفسھ بجمیع مخصصات رد الرسوم الجمركیة المعمول بھا، وعلى المشتري تقدیم العون فیما یتعلق بطلب البائع المقدم بشأنھا. 11. تنتقل الملكیة ومخاطرة الملكیة ومخاطرة الخسارة، والمخاطر األخرى .11 عند نقطة الشحن الخاصة بالبائع، ویتحمل المشتري الخسارة بالمنتج إلى المشتري التفریغ والتخزین والتنزیل ) التي تنشأ من 1كافة المخاطر والمسؤولیات ( االلتزام أو عدم االلتزام بالقوانین ) أو التي تنشأ من 2والمناولة واستخدام المنتج، ( أو اإلقلیمیة أو المحلیة التي تسري على بالوالیةواللوائح االتحادیة أو الخاصة وال یتحمل البائع المسؤولیة عن عدم تفریغ أو تنزیل أو التي تحكمھ.

If they don’t have one, follow your local security procedures immediately. 11 HOME | TOC Honesty at Work Our reputation for honesty is of significant value to our customers, suppliers, shareholders and other stakeholders, to each of us personally and to Avient. Francisco Nakasato, 1700 13295-000 Itupeva Sao Paulo, Brazil Telephone: +55 11 4593 9200 Europe Regional Headquarters Pommerloch, Luxembourg 19 Route de Bastogne Pommerloch, Luxembourg, L-9638 Telephone: +352 269 050 35 Fax: +352 269 050 45 www.avient.com http://www.avient.com

NAI-1524021340v5 11. O Vendedor não tem responsabilidade pela falha de descarregamento ou desembarque de equipamentos ou materiais usados pelo Comprador, sejam ou não fornecidos pelo Vendedor. 11.

El Vendedor se reserva todas las desgravaciones arancelarias aplicables y el Comprador prestará asistencia en 11. Buyer shall accept, as relación con la solicitud de las mismas por parte del Vendedor. 11.

Si (i) el Comprador incumple sus obligaciones hacia el Vendedor y no proporciona una garantía adecuada del cumplimiento de sus obligaciones antes de la fecha de entrega programada; o (ii) si el Vendedor tiene dudas razonables respecto al cumplimiento de las obligaciones del Comprador y este no proporciona una garantía adecuada del cumplimiento antes de la fecha de entrega programada y en cualquier caso dentro de los treinta (30) días posteriores a la solicitud del Vendedor para tal garantía; o (iii) si el Comprador se vuelve insolvente o no puede pagar sus deudas a medida que vencen, o entra en liquidación o algún procedimiento de quiebra sea iniciado por o contra el Comprador o si se nombra un síndico o receptor o administrador para la totalidad o una parte Seller reserves to itself all applicable duty drawback allowances, and Buyer shall provide assistance in connection with Seller’s application for the same. 11. El Vendedor se reserva todas las deducciones de derechos aplicables, y el Comprador proporcionará asistencia en relación con la solicitud del Vendedor para lo mismo. 11.

Versaflex™ OM3060 PP包覆成型 硬度 法规 灭菌 特性 28A 环氧乙烷 柔软的半透明材料，粘性好 43A 环氧乙烷 高度可着色的解决方案，粘性好，不易压缩变形 42A/ 50A 环氧乙烷 透明的耐高温级材料；ABS、PC可粘合 60A 环氧乙烷/蒸汽 弹性高，不易压缩变形 20A-90A 环氧乙烷 用途广泛，无填充 ABS，PC包覆成型 硬度 法规 灭菌 特性 40A USP VI级，ISO 10993 环氧乙烷 半透明 60A USP VI级，ISO 10993 环氧乙烷 透明 应用： VERSAFLEX™ CL与DYNAFLEX™ 热塑性弹性体 包覆成型，符合人体 工程学设计 • • • • • • 触感柔软，有利于形成良好的表面 有多种颜色效果和纹理可供选择 提高抓握力、缓冲力和舒适度 提高性能表现，如密封性能、减震、隔氧、 耐刮擦和耐磨性能 降低装配成本，加工性能良好 可牢固包覆于各种基材上 • • • • 血糖仪 医用工具包覆成型 注射笔 分析仪器 Dynaflex™ G2706 Dynaflex™ G2711 Versaflex™ CL2242 & CL2250 Versaflex™ G2705 N Versaflex™ HC3810 Versaflex™ OM1040 USP VI级，ISO 10993， 食品接触 USP VI级，ISO 10993， US食品接触 USP VI级，ISO 10993， 食品接触 USP VI级，ISO 10993 USP VI级，ISO 10993， 食品接触 材料描述 硬度 法规 灭菌 特性 45A USP VI级 55A USP VI级 70A USP VI级 43A 环氧乙烷 34A USP VI级， ISO 10993-4/5 FDA，USP VI级， ISO 10993 57A 挤出级，耐高温 再密封，压缩变形性能提高 摩擦低 Versalloy™ HC 9210-55N Versalloy™ HC 9210-70N Versalloy™ HC 9220-43N Versaflex™ HC 2110-35N Versaflex™ HC 2110-57B FDA，USP VI级，ISO 10993 环氧乙烷 加工性能良好，表面光洁、美观 环氧乙烷 环氧乙烷 加工性能良好，表面光洁、美观 加工性能良好，表面光洁、美观 高压灭菌、环氧乙烷、 辐射灭菌 高压灭菌、环氧乙烷、 辐射灭菌 应用： VERSALLOY™ HC与VERSAFLEX™ HC 热塑性弹性体 密封和再密封 • • • • • 柔软的橡胶质感 无抽芯，静态推塞被刺穿后再密封性良好 满足动态密封的低摩擦系数要求 可萃取物含量低 适合在聚烯烃上包覆成型 • • • 密封和密封隔膜 密封件和卫生垫圈 注射器推塞和塞头 Versalloy™ HC 9210-45N 材料描述 硬度 法规 灭菌 特性 65A/ 75A/ 84A 54A 67A 辐射灭菌 高压灭菌器 透明度高，不含增塑剂，无油 工作温度高，可高温灭菌 环氧乙烷、辐射灭菌 Versaflex™ HC MT555 Versaflex™ HC BT218 应用： VERSAFLEX™ CL与DYNAFLEX™ 热塑性弹性体 高透明度级，不含增塑剂 • • • • • • • 无色透明级，配方不含邻苯二甲酸酯增塑剂 符合医疗法规USP VI级和ISO 10993-4、5的 要求 食品接触用并符合FDA标准 可高压灭菌和辐射灭菌 可萃取物含量低 透明度高（雾度50 4.1, 100 4.5, 100 4, 70 6, 70 拉伸模量（MPa） 2200 2700 2600 2350 1820 1820 挠曲强度（MPa） 80 90 104 86 68 68 挠曲模量（MPa） 2500 2700 2500 2300 1980 1590 HDT：0.45、1.8（MPa） 110, 80 90, 80 100, 89 123, 100 123, 64 100, 70 UL-94等级，3.0mm 5VA V-0 5VA V-0 HB V-0 UL-94等级，1.5mm V-0 V-0 5VB V-0 HB V-0 UL-94等级，0.75mm V-1 V-2 V-0 无 无 V-2 竞争材料对比 医疗保健特种工程聚合物配方 TRILLIANT™ HC热塑性塑料 Trilliant™ HC高性能热塑性弹性体系列配方是专为应对日趋严苛的医疗器械和设备而开发的。

2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the establishment, reversal or changes to valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) September 30, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 439.6 $ 641.1 Accounts receivable, net 436.9 440.6 Inventories, net 349.6 372.7 Other current assets 138.2 115.3 Total current assets 1,364.3 1,569.7 Property, net 978.2 1,049.2 Goodwill 1,681.3 1,671.9 Intangible assets, net 1,563.0 1,597.6 Other non-current assets 202.9 196.6 Total assets $ 5,789.7 $ 6,085.0 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 9.5 $ 2.2 Accounts payable 389.5 454.4 Accrued expenses and other current liabilities 328.1 412.8 Total current liabilities 727.1 869.4 Non-current liabilities: Long-term debt 2,070.8 2,176.7 Pension and other post-retirement benefits 65.1 67.2 Deferred income taxes 293.2 342.5 Other non-current liabilities 337.6 276.4 Total non-current liabilities 2,766.7 2,862.8 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,276.9 2,334.5 Noncontrolling interest 19.0 18.3 Total equity 2,295.9 2,352.8 Total liabilities and equity $ 5,789.7 $ 6,085.0 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Nine Months Ended September 30, 2023 2022 Operating Activities Net income $ 47.8 $ 158.5 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 142.6 110.3 Accelerated depreciation 1.9 4.0 Share-based compensation expense 9.7 9.5 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (5.7) (66.5) Decrease (increase) in inventories 16.5 (12.5) (Decrease) increase in accounts payable (59.1) 43.5 Taxes paid on gain on sale of business (104.1) — Accrued expenses and other assets and liabilities, net (2.5) (22.9) Net cash provided by operating activities 47.1 223.9 Investing activities Capital expenditures (75.0) (55.1) Business acquisitions, net of cash acquired — (1,426.1) Settlement of foreign exchange derivatives — 93.3 Net proceeds from divestiture 7.3 — Other investing activities 2.3 — Net cash used by investing activities (65.4) (1,387.9) Financing activities Debt proceeds — 1,300.0 Purchase of common shares for treasury — (36.4) Cash dividends paid (67.6) (65.2) Repayment of long-term debt (103.8) (6.8) Debt financing costs (2.3) (49.3) Other financing (2.3) (4.2) Net cash (used) provided by financing activities (176.0) 1,138.1 Effect of exchange rate changes on cash (7.2) (30.9) Decrease in cash and cash equivalents (201.5) (56.8) Cash and cash equivalents at beginning of year 641.1 601.2 Cash and cash equivalents at end of period $ 439.6 $ 544.4 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.

2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the establishment, reversal or changes to valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) June 30, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 528.7 $ 641.1 Accounts receivable, net 506.4 440.6 Inventories, net 359.0 372.7 Other current assets 116.6 115.3 Total current assets 1,510.7 1,569.7 Property, net 1,007.4 1,049.2 Goodwill 1,705.7 1,671.9 Intangible assets, net 1,614.7 1,597.6 Other non-current assets 213.3 196.6 Total assets $ 6,051.8 $ 6,085.0 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term debt $ 2.2 $ 2.2 Accounts payable 428.7 454.4 Accrued expenses and other current liabilities 345.6 412.8 Total current liabilities 776.5 869.4 Non-current liabilities: Long-term debt 2,179.2 2,176.7 Pension and other post-retirement benefits 67.3 67.2 Deferred income taxes 304.8 342.5 Other non-current liabilities 370.3 276.4 Total non-current liabilities 2,921.6 2,862.8 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,334.7 2,334.5 Noncontrolling interest 19.0 18.3 Total equity 2,353.7 2,352.8 Total liabilities and equity $ 6,051.8 $ 6,085.0 11 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Six Months Ended June 30, 2023 2022 Operating Activities Net income $ 42.7 $ 169.2 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 96.2 71.1 Accelerated depreciation 1.9 3.2 Share-based compensation expense 6.5 6.3 Changes in assets and liabilities, net of the effect of acquisitions: Increase in accounts receivable (66.6) (133.2) Decrease (increase) in inventories 14.0 (45.9) (Decrease) increase in accounts payable (26.2) 98.5 Accrued expenses and other assets and liabilities, net (93.2) (62.5) Net cash (used) provided by operating activities (24.7) 106.7 Investing activities Capital expenditures (45.9) (34.0) Settlement of foreign exchange derivatives — 75.1 Net proceeds from divestiture 7.3 — Net cash used by investing activities (38.6) 41.1 Financing activities Purchase of common shares for treasury — (36.4) Cash dividends paid (45.0) (43.5) Repayment of long-term debt (1.0) (4.4) Other financing (2.3) (4.1) Net cash used by financing activities (48.3) (88.4) Effect of exchange rate changes on cash (0.8) (15.5) Decrease in cash and cash equivalents (112.4) 43.9 Cash and cash equivalents at beginning of year 641.1 601.2 Cash and cash equivalents at end of period $ 528.7 $ 645.1 12 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.